3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
34
Lung Neoplasms
23
Carcinoma, Non-Small-Cell Lung
18
Neoplasms
15
Uterine Cervical Neoplasms
9
Esophageal Neoplasms
9
Brain Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Solid Tumor
7
Rectal Neoplasms
7
Lymphoma
7
Glioblastoma
7
Carcinoma, Hepatocellular
7
Prostatic Neoplasms
6
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Melanoma
6
Hodgkin Disease
6
Colorectal Neoplasms
6
Colonic Neoplasms
6
Carcinoma, Renal Cell
6
Breast Neoplasms, Male
6
Stomach Neoplasms
5
Sarcoma
5
Neuroendocrine Tumors
5
Lymphoma, Large B-Cell, Diffuse
5
Carcinoma, Transitional Cell
5
Thyroid Neoplasms
4
Ovarian Neoplasms
4
Interventions
Enoxaparin
3
Tinzaparin
2
Saline Solution
2
Heparin, Low-Molecular-Weight
2
Heparin
2
Gemcitabine
2
Fondaparinux
2
Dalteparin
2
130-nm albumin-bound paclitaxel
2
palbociclib
1
enoxaparin sodium
1
edoxaban
1
apixaban
1
Warfarin
1
Tranexamic Acid
1
Sodium Chloride
1
Sodium Bicarbonate
1
Rivaroxaban
1
Pentetic Acid
1
PEGPH20
1
Minocycline
1
Ketoconazole
1
Fluorodeoxyglucose F18
1
Fluoridation
1
Estramustine
1
Enzyme-Linked Immunosorbent Assay
1
Doxorubicin
1
Docetaxel
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thromboembolism
×
Fluorodeoxyglucose F18
×
Clear all
NCT00964275
2014-12-08
MVTEP
University Hospital, Brest
Phase NA
Completed
400 enrolled